Prescription drug · ANDA
GaviLyte-H and Bisacodyl NDC 43386-071
Kit · Oral · Lupin Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 43386-071-83 | 4338600718343386007183 | 1 KIT in 1 KIT (43386-071-83) * 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (43386-010-61) * 2 L in 1 BOTTLE (43386-070-17)Marketed from Apr 21, 2015 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- GaviLyte-H and Bisacodyl
- Generic name (nonproprietary)
- polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride and bisacodyl delayed-release tablet
- Dosage form
- Kit
- Route
- Oral
- Labeler
- Lupin Pharmaceuticals, Inc.NDC labeler code 43386
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202217
- Marketing start
- Listing expires
- Identifiers
- Product ID 43386-071_c34cfe17-96c2-4f07-8a2d-74bc84e61fb4SPL ID c34cfe17-96c2-4f07-8a2d-74bc84e61fb4SPL set ID 78fe1c29-e22a-4615-a2f9-a61cd4eb38a3RxCUI 308753, 1000479, 1718983, 1718990, 1718991UPC 0343386205028
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N443386007183followed by a unit qualifier and the quantityPackage 43386-0071-83. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
GaviLyte - H and bisacodyl delayed-release tablet, USP is indicated for cleansing of the colon as a preparation for colonoscopy in adults. GaviLyte - H and bisacodyl delayed-release tablet, USP is a combination of PEG-3350, an osmotic laxative and bisacodyl, a stimulant laxative, indicated for cleansing of the colon as a preparation for colonoscopy in adults ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 43386-071
- What is NDC 43386-071?
- 43386-071 is the product NDC for GaviLyte-H and Bisacodyl kit, listed with the FDA by Lupin Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- GaviLyte-H and Bisacodyl (Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet).
- Who is the labeler?
- Lupin Pharmaceuticals, Inc., NDC labeler code 43386. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for GaviLyte-H and Bisacodyl?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.